Reply to Hu et al: Could there be detrimental effects of statin adjunctive TB therapy on immune responses?

J Infect Dis. 2020 Jun 29;222(2):336-337. doi: 10.1093/infdis/jiz676.

Authors

Noton K Dutta¹, Petros C Karakousis^{1

2}

Affiliations

¹ Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
² Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

No abstract available

Publication types

Letter
Comment

MeSH terms

Animals
Combined Modality Therapy
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
Immunity
Mice
Tuberculosis* / drug therapy

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Grants and funding